Evidence map›Paper›PMID 17090655›Full record

ArticleBlood2007

K1 protein of human herpesvirus 8 suppresses lymphoma cell Fas-mediated apoptosis.

Suizhao Wang, Shu Wang, Hoyoung Maeng, Daniel P Young, Om Prakash, Luis E Fayad, Anas Younes, Felipe Samaniego

Open access · greenAbstract read
In one paragraph

Article in Blood, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 44 citations in OpenAlex.

  1. Review
  2. Review
  3. The Role of Lytic Infection for Lymphomagenesis of Human γ-Herpesviruses.Frontiers in cellular and infection microbiology · 2021
    Review
  4. Review
  5. Journal of virology · 2019
    Review
  6. Article
  7. Article
  8. Review
  9. Immune control of oncogenic γ-herpesviruses.Current opinion in virology · 2015
    Review
  10. Article
  11. Review
  12. Article
  13. CD74 interferes with the expression of fas receptor on the surface of lymphoma cells.Journal of experimental & clinical cancer research : CR · 2014
    Article
  14. Review
  15. Article
  16. Oncogenes and RNA splicing of human tumor viruses.Emerging microbes & infections · 2014
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Suizhao WangDepartment of Lymphoma and Myeloma, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.
Shu Wang
Hoyoung Maeng
Daniel P Young
Om Prakash
Luis E Fayad
Anas Younes
Felipe Samaniego
The University of Texas MD Anderson Cancer Center · USMolecular Oncology (United States) · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
Lymphoid Transformation with Human Herpesvirus 8 K1K22CA098412 · NCI · UNIVERSITY OF TEXAS MD ANDERSON CAN CTR · PI SAMANIEGO, FELIPE · 2003 to 2005
$473k
PKB/Akt Activation and Cell Survival with HIV-1 TatR21CA106173 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI SAMANIEGO, FELIPE · 2005 to 2006
$255k
NCI NIH HHS CA098412NCI NIH HHS CA106173NCI NIH HHS CA16672NCI NIH HHS K22 CA098412NCI NIH HHS P30 CA016672NCI NIH HHS R21 CA106173
6 · The paper itself

Abstract

Expression of the K1 gene of human herpesvirus 8 activates nuclear factor-kappaB and induces lymph node hyperplasia and lymphomas in transgenic mice. To further delineate its role in cell survival, we determined whether K1 altered apoptosis of lymphoma cells. K1 protein is expressed in Kaposi sarcoma and primary effusion lymphoma. We retrovirally transfected BJAB lymphoma, THP-1, U937, and Kaposi sarcoma SLK cells to express K1 and a K1 mutant with the deleted immunoreceptor tyrosine-based activation motif (K1m). We challenged cells with an agonistic anti-Fas antibody, Fas ligand, irradiation, and tumor necrosis factor-related apoptosis-inducing ligand. K1 transfectants but not K1m transfectants exhibited reduced levels of apoptosis induced by the anti-Fas antibody but not apoptosis induced by the tumor necrosis factor-related apoptosis-inducing ligand or irradiation. K1 expression resulted in reduced apoptosis rates as shown in several assays. K1 induced a modest reduction in levels of Fas-associated death domain protein, and procaspase 8 recruited to the death-inducing signaling complex. Finally, K1 transfectants cleaved procaspase 8 at significantly lower rates than did K1m transfectants. K1-transfected mice, compared with vector-transfected mice, showed lower death rates after challenge with anti-Fas antibody. K1 may contribute to lymphoma development by stimulating cell survival by selectively blocking Fas-mediated apoptosis.

Indexed as

ApoptosisAntibodiesCell Line, Tumorfas ReceptorGene ExpressionHumansLymphomaPlasmidsSurvival RateTransfectionViral ProteinsAntibodiesfas ReceptorK1 protein, Human herpesvirus 8Viral Proteins

Identifiers

PMID17090655
PMCPMC1801039
OpenAlexW2044387903

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.